T he concept of specialized suppressor T cells (now commonly called regulatory T cells or Tregs), which was abandoned by most immunologists in the early 1980s (1) , was rescued by the description of a marker for their identification and isolation by Sakaguchi et al. (2) , who, in 1995, described a CD4 ϩ CD25 ϩ subpopulation of T cells that could prevent pathology in a mouse autoimmune disease model. However, the marker CD25, the ␣-chain of the high-affinity IL-2 receptor, is also induced on conventional T cells after activation. The dilemma arose as to how one could distinguish genuine Tregs from recently activated conventional T cells. Furthermore, the suppressor activity of CD4 ϩ CD25 ϩ Tregs in vitro depended on their prior stimulation and could be overcome by strong costimulation (3, 4 
The Two-Signal Model of T Cell Activation Revisited
A major paradigm of current immunology is that the initiation of an immune response requires an antigen-specific first signal and additional second signal(s) induced by ''danger'' or ''foreignness.'' A popular version of the twosignal model for T cell activation, described a few years ago, focused on B7-1 and B7-2 molecules expressed on APCs as the main providers of T cell costimulation (8) . In this model, T cells are activated through the interaction of peptide͞MHC complexes and B7-1͞ B7-2 molecules on the APC with, respectively, the T cell antigen receptor (first signal) and constitutively expressed CD28 (second signal). Full T cell activation induces expression of the negative regulatory molecule CTLA-4, an alternative ligand for B7-1 and B7-2, which then turns off the immune response. Over the past several years, it has become clear that the initiation of an immune response is a much more complex process. Additional B7 family members expressed on APCs and their respective ligands on T cells have been identified, including B7h͞ICOS and the negative regulatory PDL1ϩ2͞PD-1 (9). Furthermore, other classes of receptors have been shown to be involved in the regulation of immune responses, including tumor necrosis factor receptor family members like OX40, 4-1BB, and their ligands (10) . Some of these costimulatory ligand͞receptor pairs are constitutively expressed, whereas others are induced upon activation. There appears to be a hierarchy of costimulatory ligand͞ receptor combinations in the control of immune responses, e.g., CTLA-4 knockout mice die within 3-4 weeks from a severe lymphoproliferative syndrome (11), whereas PD-1 knockout mice develop a far more subtle lupus-like disease later in life (12) . In fact, costimulatory receptors appear to differentially affect certain aspects of the immune response such as proliferation, survival, and effector cell differentiation (10) . Another layer of complexity is added to the two-signal model by the demonstration of the CD4 ϩ CD25 More recent concepts of CTLA-4 function suggest that it inhibits the expansion of high-affinity T cell clones within a polyclonal responder population (19) . The role of CTLA-4 for CD4 ϩ CD25 ϩ Treg cells could thus be to maintain a broad range of T cell antigen receptor specificities and, assuming a largely selfrestricted repertoire, prevent the development of repertoire holes that could result in autoimmune responses. Finally, a number of other tumor necrosis factor receptor family members appear to be differentially expressed on CD4 ϩ CD25 ϩ Tregs (20) . However, no evidence has been reported yet that any of these can be used as additional Treg markers, or that they have functions similar to GITR. Signaling via GITR is unique in that it both turns off CD4 
